Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters

Despite various attempts to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients with COVID-19 convalescent plasmas, neither appropriate approach nor clinical utility has been established. We examined the efficacy of administration of highly neutralizing COVID-19 conv...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamatsu, Yuki, Imai, Masaki, Maeda, Kenji, Nakajima, Noriko, Higashi-Kuwata, Nobuyo, Iwatsuki-Horimoto, Kiyoko, Ito, Mutsumi, Kiso, Maki, Maemura, Tadashi, Takeda, Yuichiro, Omata, Kazumi, Suzuki, Tadaki, Kawaoka, Yoshihiro, Mitsuya, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865546/
https://www.ncbi.nlm.nih.gov/pubmed/34818068
http://dx.doi.org/10.1128/jvi.01551-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865546/
https://www.ncbi.nlm.nih.gov/pubmed/34818068
http://dx.doi.org/10.1128/jvi.01551-21

Ejemplares similares